110958-19-5

Fasoracetam

Fasoracetam

Another Name:
CasNo.: 110958-19-5
MF: C10H16 N2 O2
MW: 196.249
Storage:
Online consultation
ch_Name: Fasoracetam
English name: Fasoracetam
CasNo.: 110958-19-5
MF: C10H16 N2 O2
MW: 196.249

Fasoracetam Good Supplier In Bulk Supply High Purity 110958-19-5

  • Molecular Formula:C10H16 N2 O2
  • Molecular Weight:196.249
  • Vapor Pressure:1.57E-08mmHg at 25°C 
  • Boiling Point:456.8°Cat760mmHg 
  • PKA:15.45±0.40(Predicted) 
  • Flash Point:230.1°C 
  • PSA:49.41000 
  • Density:1.181g/cm3 
  • LogP:0.54420 

FASORACETAM(Cas 110958-19-5) Usage

General Description

Fasoracetam is a synthetic compound that belongs to the racetam family of nootropics, which are known for their cognitive enhancing properties. It is often used as a study aid and to improve memory and learning. Fasoracetam works by modulating the activity of neurotransmitters in the brain, specifically by targeting the glutamate and GABA systems. It is believed to have potential for treating conditions such as ADHD and anxiety, and has shown promise in animal studies for its potential neuroprotective and antidepressant effects. While more research is needed to fully understand its mechanisms and potential therapeutic uses, fasoracetam is considered to be a safe and well-tolerated compound when used at appropriate doses.

InChI:InChI=1/C10H16N2O2/c13-9-5-4-8(11-9)10(14)12-6-2-1-3-7-12/h8H,1-7H2,(H,11,13)/t8-/m1/s1

110958-19-5 Relevant articles

SOLID FORMS OF FASORACETAM

-

Paragraph 00741; 00742, (2019/08/08)

The disclosure is directed to cocrystals...

Protecting-Group-Free Amidation of Amino Acids using Lewis Acid Catalysts

Sabatini, Marco T.,Karaluka, Valerija,Lanigan, Rachel M.,Boulton, Lee T.,Badland, Matthew,Sheppard, Tom D.

, p. 7033 - 7043 (2018/05/04)

Amidation of unprotected amino acids has...

Synthesis of chiral diamines using novel 2-trichloromethyloxazolidin-4-one precursors derived from 5-oxo-proline and proline

Amedjkouh, Mohamed,Ahlberg, Per

, p. 2229 - 2234 (2007/10/03)

Efficient syntheses of chiral vicinal di...

Pyroglutamide derivatives

-

, (2008/06/13)

Pyroglutamide derivatives have been foun...

110958-19-5 Process route

piperidine
110-89-4

piperidine

D-pyrrolidone-5-carboxylic acid
4042-36-8

D-pyrrolidone-5-carboxylic acid

Fasoracetam
110958-19-5

Fasoracetam

Conditions
Conditions Yield
In acetonitrile;
In ethyl acetate;
D-pyrrolidone-5-carboxylic acid
4042-36-8

D-pyrrolidone-5-carboxylic acid

Fasoracetam
110958-19-5

Fasoracetam

Conditions
Conditions Yield
Multi-step reaction with 2 steps
1: PTSA / toluene / 16 h / Heating
2: acetonitrile / 0.17 h / 20 °C
With toluene-4-sulfonic acid; In toluene; acetonitrile;

110958-19-5 Upstream products

  • 110-89-4
    110-89-4

    piperidine

  • 4042-36-8
    4042-36-8

    D-pyrrolidone-5-carboxylic acid

  • 56-86-0
    56-86-0

    L-glutamic acid

110958-19-5 Downstream products

  • 575469-26-0
    575469-26-0

    (R)-2-[(piperidin-1-yl)methyl]pyrrolidine

No data available
No data available